The big data to intelligence project [led by Signals] told us that patients wanted a better taste... the next step was to implement the insights for all our new drugs. The impact of the project has been widespread," says Heresh Rezavandi, UCB's ecosystem strategic intelligence lead. See today's article in Pharma Times on how Signals is helping UCB and other companies find innovative approaches to go "Beyond the Pill."

Learn more here.